期刊文献+

更昔洛韦眼用凝胶对单纯疱疹病毒性角膜炎角膜上皮及泪膜稳定性的影响 被引量:9

Ganciclovir gel on corneal epithelial and stabilities of tear film in herpes simplex keratitis
下载PDF
导出
摘要 目的探讨更昔洛韦眼用凝胶对单纯疱疹病毒性角膜炎角膜上皮及泪膜稳定性的影响。方法采用前瞻性随机双盲试验,将45例上皮型单纯疱疹病毒性角膜炎患者分3组:A组15例,用1.5g·L-1更昔洛韦凝胶滴眼;B组15例,用1g·L-1更昔洛韦滴眼液滴眼;C组15例,用1g·L-1阿昔洛韦滴眼液滴眼。双眼用药,均为每天4次,健眼观察局部用药对角膜上皮及泪膜稳定性的影响。用药前和用药后21d检查,记录健眼角膜上皮染色(fluorescein staining,FL)评分、泪膜破裂时间(break up time,BUT)、泪液分泌试验(Schirmer I test,SⅠt)和泪河高度(tear meniscus height,TMH)。结果A组用药前后FL、SⅠt及TMH均无明显改变,BUT延长;B组用药后有3例发生角膜上皮点状着色,BUT缩短率为33.33%,SⅠt和TMH改变不明显;C组用药后有6例发生角膜上皮点状着色,BUT缩短(缩短率为53·33%),SⅠt减少,TMH降低。A、C2组用药后各指标间差异有统计学意义,B组用药后BUT小于A组。结论1.5g·L-1更昔洛韦凝胶能保护眼表上皮细胞,减少药物毒性的作用,可提高泪膜稳定性,有利于促进疾病痊愈,缩短治疗时间。 Objective To investigate the topical application of ganciclovir gel on corneal epitheium and stability of tear film in herpes aimplex keratitis. Methods A randomised double blind prospective clinical trial was carried out on 45 cases with epithelial herpes simplex keratitis. All the cases were divided into three groups, Group A ( 15 cases) were treated with 1.5 g · L^-1 ganciclovir gel, Group B ( 15 cases) were treated with 1 g · L^-1 ganciclovir drop, and Group C( 15 cases) were treated with 1 g · L^-1 aciclovir drop,four times a day on both eyes. Curative effect was observed on sick eyes, while the effect of topical application on corneal epithelium and stability of tear film was observed on healthy eyes. Fluorescein staining ( FL), tear film break up time (BUT), Schirmer I test (S I t) and tear meniscus height (TMH) were recorded pre-therapy and at 21 days post-therapy. Resuits The score of FL, ST and TMH in Group A had no difference after topical application of ganciclovir gel,however,BUT increased at 21 days post-therapy;3 cases in Group B had punctate epithelial staining, BUT was decreased to 33.33% ;6 cases in Group C had punctuate epithelial staining, either of BUT, S I t and TMH decreased ( P = 0. 020,0. 002,0. 005 respectively). The difference of scores between Group A and Group C was significant, and BUT in Group B was shorter than that of Group A after application of ganciclovir gel. No obviously adverse drug reaction was found in all of the three groups. Conclusion Ganciclovir gel with 1.5 g · L^-1 can protect ocular epithelial cells effectively and increase the stabilities of tear film, and also can improve symptom early and shorten the curative time of herpes simplex keratitis.
作者 高娜 黄挺
出处 《眼科新进展》 CAS 2008年第10期775-777,共3页 Recent Advances in Ophthalmology
关键词 单纯疱疹病毒性角膜炎 更昔洛韦 阿昔洛韦 herpes simplex keratitis ganciclovir aciclovir
  • 相关文献

参考文献7

  • 1刘祖国.单纯疱疹病毒性角膜炎.李凤鸣.中华眼科学[M].北京:人民卫生出版社,2005:1220-1224.
  • 2黄挺,高娜,王玉娟.更昔洛韦眼用凝胶治疗上皮型单纯疱疹病毒性角膜炎的疗效观察[J].眼科新进展,2008,28(4):297-299. 被引量:16
  • 3Kaye S, Choudhary A. Herpes simplex keratitis [ J ]. Prog Retin Eye Res 2006;25(4) :355-380.
  • 4Green LK, Pavan-Langston D. Herpes simplex ocular inflammatary disease[J]. Int Ophthalmol Clin 2006;46(2) : 27 -37.
  • 5Anderson NJ, Edelhauser HF. Toxicity of ocular surgical solutions [ J]. Int Ophthalmol Clin 1999 ;39 (2) :91-106.
  • 6Huhtala A, Mannerstrom M ,Alajuuma P, Nurmi S, Toimela T,Tahti H, et ol. Comparison of an immortalized human corneal epithelial cell line and rabbit corneal epithelial cell culture in cytotoxicity testing[ J]. J Ocul Pharmacol Ther 2002;18(2) :163-175.
  • 7杨宝铃,金秀英,吴志洁,孙晓琴.更昔洛韦滴眼剂治疗单疱病毒角膜炎137例临床研究[J].眼科,2000,9(5):297-299. 被引量:19

二级参考文献14

  • 1赵林,刘新,王树纲,黄红深,张繁友.更昔洛韦眼用凝胶在单纯疱疹病毒性角膜炎中的应用[J].眼科新进展,2006,26(11):809-809. 被引量:17
  • 2金秀英,杨宝铃,等.丙氧鸟苷滴眼剂治疗单疱病毒角膜炎的临床研究.第五届全国核酸和核苷学术会议论文汇编,1997,11.
  • 3PouliquenP,ElenaPP,MalecazeF,etal.Assessmentofthesafetyandlocalpharmacokineticsofa0.15%gelofganciclovir(Virgan)inhealthyvolunteers.InvestOphthalmolVisSci,1996,37(3):313.
  • 4ColinJ,HohHB,etal,Ganciclovirophthalmicgel(Virgan0.15%)inthetreatmentofherpessimplexkeratitis.Cornea,1997,16(4):393-399.
  • 5HohHB,HurleyC,ClaoueC,etal.Randomisedtrialofganciclovirandacyclovirinthetreatmentofherpessimplexdendritickeratitis:amulticentrestudy.BrJOphthalmol,1996,80(3):140-143.
  • 6MatthewT,BoehmeR.Antiviralactivityandmechanismofactionofganciclovir.Reviewsofinfectiousdiseases,1988,10(Suppl.1):490-494.
  • 7Kaye S, Choudhary A. Herpes simplex keratitis[J]. Prog Retin Eye Res 2006 ;25 (4) :355-380.
  • 8Green LK, Pavan-Langston D. Herpes simplex ocular inflammatary disease[J]. Int Ophthalmol Clin 2006;46(2) : 27 -37.
  • 9Hosseini H, Khalili MR. Therapeutic potential of bevacizumab in herpetic stromal keratitis (HSK) [ J ]. Med Hypotheses 2007 ;69 ( 3 ) :568-570.
  • 10Mott KR,Osorio Y,Maguen E,Nesburn AB, Wittek AE, Cai S,et al. Role of anti-glycoproteins D (anti-gD) and K (anti-gK) IgGs in pathology of herpes stromal keratitis in humans [ J]. Invest Ophthalmol Vis Sci 2007 ; 48 ( 5 ) : 2185- 2193.

共引文献31

同被引文献49

引证文献9

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部